DENVER, Oct. 20 /PRNewswire-FirstCall/ -- Wyndgate Technologies(R), a division of Global Med Technologies(R), Inc., (OTC:GLOB) (BULLETIN BOARD: GLOB) announced today that customers at more than 500 sites across the country have licensed its products. (Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO ) Wyndgate manufactures information management software for donor centers and transfusion services. The Company's SafeTrace(R) donor management system has been accepted by both large and small blood centers as well as hospital-based donor centers. Wyndgate additionally manufactures and sells its SafeTrace Tx(R) system, a transfusion management system, which is also provided as the blood bank solution accompanying full-suite laboratory information systems from channel partner vendors. "In 2005, Global Med and Wyndgate set their sights on reaching 500 customer sites. We are pleased to announce that since 2005, we have successfully added over 200 new sites to our growing customer base and met our projected goal. Our next major milestone is 1,000 customer installations," stated Michael I Ruxin, M.D., Chairman and CEO of Global Med Technologies. Dr. Ruxin continued, "As anticipated, our continued growth in the blood banking industry has resulted in continued growth in our profits and the stability of our company. This growth speaks to the strength of our pipeline, our ability to close sales and the loyalty of our customers. This milestone is truly a testament to the quality of Wyndgate's products, the success of our Service 360(TM) commitment and the allegiance of our customers." About Global Med Technologies, Inc. Global Med Technologies, Inc. is an international e-Health, medical information technology company, providing information management software products and services to the healthcare industry. Its Wyndgate Technologies division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Each year, Wyndgate's products and services manage more than eight million blood components, representing over 27% of the U.S. blood supply. Wyndgate's products are being used in Canada and sub-Saharan Africa, and are being implemented in the Caribbean. Together, the SafeTrace Tx(R)* advanced transfusion management system and the SafeTrace(R) donor management system provide Vein-to-Vein(R) tracking from donor collection to patient transfusion. For more information about Global Med's products and services, please call 800-WYNDGATE or visit http://www.globalmedtech.com/, http://www.peoplemed.com/ and http://www.wyndgate.com/. This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release. http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies, Inc. CONTACT: Michael I. Ruxin, M.D., of Global Med Technologies, Inc., +1-303-238-2000 Web site: http://www.globalmedtech.com/

Copyright